Collene R. Jeter, Ph.D.
Department of Epigenetics and Molecular Carcinogenesis, Division of Discovery Science
About Dr. Jeter
Dr. Jeter has ~15 years of experience performing detailed cell and molecular analyses of normal and tumor tissues contributing to our understanding of molecular oncogenesis. Her lab dissected the mechanisms underlying NANOG-mediated oncogenesis and prostate cancer progression to castration resistance. Other ongoing collaborative research includes studies of DNA damage repair, protein subcellular localization and dynamics, cancer cell metastasis and cell-fate specification. Her independent research aiming to ascertain how attributes of stem cells fuel tumorigenesis largely centered on confocal microscopy. Advanced confocal includes volumetric high-resolution multispectral imaging, protein-protein interaction assays, super-resolution imaging, biological phenotyping and time-lapse imaging. The recent addition of a Leica TCS SP8 DIVE multiphoton microscope has permitted the development of 3D volumetric and intravital imaging. Dr. Jeter currently manages the EMC departmental LSM880 laser scanning confocal and multiphoton microscopes and as Co-Director of the Flow Cytometry and Cell Imaging Core, trains all departmental users and continues to develop advanced confocal, multiphoton and supportive wet lab capabilities at her facility. User training, protocol development and collaborative confocal imaging requests are welcome.
Present Title & Affiliation
Primary Appointment
Research Associate Professor, Department of Epigenetics and Molecular Carcinogenesis, Division of Discovery Science, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Research Associate Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas
Research Interests
Dr. Jeter's research aims to illuminate tumor heterogeneity and the stem cell attributes of cancer cells. Potentially encompassing both the cancer cell-of-origin and oncogenic reprogramming they apply laser scanning confocal microscopy to investigate neoplastic stem-like cells in situ and NextGen Sequencing to query gene expression profiles of purified candidate CSCs ex vivo. Using these cutting-edge methods, the pluripotency factor NANOG convergence on the master transcription factors AR and FOXA1 (Jeter et al., 2016) was recently discovered to underlie NANOG-mediated prostate cancer castration-resistance phenotypes and gene signatures (Jeter et al., 2011). Fluorescence-tagged transgenic mouse models are also being applied to query tumor development and cancer origins via confocal and RNA-Seq transcriptome profiling, such as a novel prostate-specific dox-repressible H2B-GFP label-retaining cell system utilized to characterize a luminal stem/progenitor cell implicated in prostate homeostasis and prostate cancer. Currently they are working to establish methods to interrogate cancer stem cell reprogramming of the bone marrow niche, an event that may presage or augment bone metastases. Other interests include: 3D reconstructions and imaging of thicker tissue/tumor specimens, time-lapse imaging and lineage tracing, molecular mechanisms of DNA damage repair, and protein proximity and dynamics (e.g., FRET/FRAP). As director of Cell Imaging (part of our Flow Cytometry and Cell Imaging Core) at UT MD Anderson Cancer Center, collaborative investigations in any of these imaging areas are welcome.
Education & Training
Degree-Granting Education
| 2004 | The University of Texas, Austin, Texas, US, Molecular and Cellular Biology, Ph.D |
| 1993 | The University of Texas, Austin, Texas, US, Molecular Biology, BS |
Postgraduate Training
| 2004-2009 | Research Fellowship, Molecular mechanisms of tumorigenesis and cancer cell biology, The University of Texas MD Anderson Cancer Center, Smithville, Texas |
Experience & Service
Academic Appointments
Research Assistant Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2016 - 2024
Instructor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2009 - 2016
Postdoctoral Fellow, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, 2004 - 2009
Ph.D. Candidate, Department of Cellular and Molecular Biology, The University of Texas, Austin, TX, 2001 - 2004
Graduate Research Assistant, Department of Cellular and Molecular Biology, The University of Texas, Austin, TX, 1998 - 2004
Administrative Appointments/Responsibilities
Interim Director, Department of Advanced Microscopy Core, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Co-Director, Department of Flow Cytometry and Cell Imaging Core, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Other Appointments/Responsibilities
Research Assistant, The University of Texas, Austin, TX, 1998 - 1998
Sr. Research Assistant, The University of Texas Health Science Center, San Antonio, TX, 1996 - 1998
Sr. Lab Tech/Assistant Scientist, The University of Minnesota Mayo Clinic, Minneapolis, MN, 1994 - 1996
Institutional Committee Activities
Executive Oversight Committee Board Member, Recombinant Antibody Protein Core (RAPC), 2023 - Present
Member, South Campus Research Building 5 (SCR5) Planning Committee, 2022 - Present
Member, Shared Resource Committee (SHREC), 2021 - 2022
Member, Shared Resource and Service Center Oversight Committee, 2019 - Present
Chair, Postdoctoral Association, Mentor Award Subcommittee, 2007
Chair, Postdoctoral Association, Science Park Subcommittee, 2005 - 2006
Member, Postdoctoral Association, Steering Committee, 2004 - 2009
Honors & Awards
| 2017 | MBL Fellowship (Marine Biological Laboratories Optical Microscopy & Imaging Course) |
| 2009 | Outstanding Graduate Scholar, American Urological Association Research Foundation |
| 2007 - 2009 | Research Scholar, American Urological Association Research Foundation |
| 2004 - 2006 | Ruth L. Kirschstein National Research Service Award, University of Texas M.D. Anderson Cancer Center |
| 2003 | Bruton Fellow, University of Texas at Austin |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Awasthi, S, Dobrolecki, LE, Sallas, C, Zhang, X, Li, Y, Khazaei, S, Ghosh, S, Jeter, CR, Liu, J, Mills, GB, Westin, SN, Lewis, MT, Peng, W, Sood, AK, Yap, TA, Yi, SS, McGrail, DJ, Sahni, N. UBA1 inhibition sensitizes cancer cells to PARP inhibitors. Cell Reports Medicine 5(12), 2024. e-Pub 2024. PMID: 39626673.
- Mise, K, Long, J, Galvan, D, Ye, Z, Fan, G, Sharma, R, Serysheva, I, Moore, TI, Jeter, CR, Anna Zal, M, Araki, M, Wada, J, Schumacker, PT, Chang, B, Danesh, FR. NDUFS4 regulates cristae remodeling in diabetic kidney disease. Nature communications 15(1), 2024. e-Pub 2024. PMID: 38438382.
- Patel, B, Zhou, Y, Babcock, R, Ma, F, Zal, MA, Kumar, D, Medik, YB, Kahn, LS, Pineda, JE, Park, EM, Schneider, S, Tang, X, Raso, G, Jeter, CR, Zal, T, Dwyer, KC, Keyomarsi, K, Giancotti, FG, Colla, S, Watowich, SS. STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response. Leukemia 38(5):1143-1155, 2024. e-Pub 2024. PMID: 38467768.
- Bratton S, Wible D, Parikh Z, Cho EJ, Chen MD, Jeter C, Mukhopadhyay S, Dalby K, Varadarajan S. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control. Cell Death & Disease, 2024. e-Pub 2024.
- Wible, D, Parikh, Z, Cho, EJ, Chen, M, Jeter, CR, Mukhopadhyay, S, Dalby, KN, Varadarajan, S, Bratton, SB. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control. Cell Death and Disease 15(1), 2024. e-Pub 2024. PMID: 38253602.
- Li, Y, Dobrolecki, LE, Sallas, C, Zhang, X, Kerr, TD, Bisht, D, Wang, Y, Awasthi, S, Kaundal, B, Wu, S, Peng, W, Mendillo, ML, Lu, Y, Jeter, CR, Peng, G, Liu, J, Westin, SN, Sood, AK, Lewis, MT, Das, J, Yi, S, Bedford, MT, McGrail, DJ, Sahni, N. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. Cell Reports Medicine 4(12), 2023. e-Pub 2023. PMID: 38118413.
- Hussain T, Sanchez K, Crayton J, Saha D, Jeter CR, Lu Y, Abba M, Seo R, Noebels JL, Fonken L, Aldaz CM. WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12. Prog Neurobiol 223(IF- 11.7):102425, 2023. e-Pub 2023. PMID: 36828035.
- Yang F, Chen J, Liu B, Gao G, Sebastian M, Jeter CR, Shen J, Person MD, Bedford MT. SPINDOC binds PARP1 to facilitate PARylation. Nat Commun 12(1):6362, 2021. e-Pub 2021. PMID: 34737271.
- Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter CR, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG. Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun 11(1):2895, 2020. e-Pub 2020. PMID: 32499578.
- Li Q, Liu B, Chao HP, Ji Y, Lu Y, Mehmood R, Jeter CR, Chen T, Moore JR, Li W, Liu C, Rycaj K, Tracz A, Kirk J, Calhoun-Davis T, Xiong J, Deng Q, Huang J, Foster BA, Gokhale A, Chen X, Tang DG. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun 10(1):5494, 2019. e-Pub 2019. PMID: 31792211.
- Koutelou E, Wang L, Schibler AC, Chao HP, Kuang X, Lin K, Lu Y, Shen J, Jeter CR, Salinger A, Wilson M, Chen YC, Atanassov BS, Tang DG, Dent SYR. USP22 controls multiple signaling pathways that are essential for vasculature formation in the mouse placenta. Development 146(4), 2019. e-Pub 2019. PMID: 30718289.
- Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter CR, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, Beltran H, Shen J, Chatta G, Puzanov I, Mohler JL, Wang J, Zhao R, Kirk J, Chen X, Tang DG. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9(1):3600, 2018. e-Pub 2018. PMID: 30190514.
- Zhang D, Jeter CR, Gong S, Tracz A, Lu Y, Shen J, Tang DG. Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration. Stem Cell Reports 10(1):228-242, 2018. e-Pub 2018. PMID: 29276153.
- Wang L, Koutelou E, Hirsch C, McCarthy R, Schibler A, Lin K, Lu Y, Jeter CR, Shen J, Barton MC, Dent SYR. GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes during Early Embryoid Body Differentiation. Stem Cell Reports 10(1):287-299, 2018. e-Pub 2018.
- Liu B, Gong S, Li Q, Chen X, Moore J, Suraneni MV, Badeaux MD, Jeter, CR, Shen J, Mehmood R, Fan Q, Tang DG. Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model. Oncotarget 8(32):52746-60, 2017. e-Pub 2017.
- Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, Tang DG. NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Disc 2:16041, 2016. e-Pub 2016.
- Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter CR, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG. Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer. Clin Cancer Res 22(17):4505-16, 2016. e-Pub 2016.
- Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter CR, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. Oncotarget. e-Pub 2016.
- Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter CR, Liu C, Honorio S, Li H, Davis T, Suraneni M, Laffin B, Qin J, Li Q, Yang T, Whitney P, Shen J, Huang J, Tang DG. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget 6(27):23959-86, 2015. e-Pub 2015.
- Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter CR, Chen X, Vlassov AV, Tang DG. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 74(15):4183-95, 2014. e-Pub 2014. PMID: 24903149.
- Liu B, Badeaux MD, Choy G, Chandra D, Shen I, Jeter CR, Rycaj K, Lee CF, Person MD, Liu C, Chen Y, Shen J, Jung SY, Qin J, Tang DG. Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species. PLoS One 9(3):e90615, 2014. e-Pub 2014. PMID: 24598770.
- Ferguson BW, Gao X, Zelazowski MJ, Lee J, Jeter CR, Abba MC, Aldaz CM. The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding. BMC Cancer 13:593, 2013. e-Pub 2013.
- Badeaux MA, Jeter CR, Gong S, Liu B, Suraneni MV, Rundhaug J, Fischer SM, Yang T, Kusewitt D, Tang DG. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle 12(15):2395-408, 2013. e-Pub 2013. PMID: 23839044.
- Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10(5):556-69, 2012. e-Pub 2012. PMID: 22560078.
- Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ, Tang DG. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30(36):3833-3845, 2011. e-Pub 2011.
- Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter CR, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17(2):211-5, 2011. e-Pub 2011.
- Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27(5):993-1005, 2009. e-Pub 2009. PMID: 19415763.
- Chen X, Schneider-Broussard R, Hollowell D, McArthur M, Jeter CR, Benavides F, DiGiovanni J, Tang DG. Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. Differentiation 77(3):324-34, 2009. e-Pub 2009. PMID: 19272531.
- Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG. Methodologies in assaying prostate cancer stem cells. Methods Mol Biol 568:85-138, 2009. e-Pub 2009. PMID: 19582423.
- Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, Tang DG. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. J Biol Chem 283(41):27957-72, 2008. e-Pub 2008. PMID: 18662989.
- Jeter CR, Roux SJ. Plant responses to extracellular nucleotides: Cellular processes and biological effects. Purinergic Signal 2(3):443-9, 2006. e-Pub 2006. PMID: 18404482.
- Jeter CR, Tang W, Henaff E, Butterfield T, Roux SJ. Evidence of a novel cell signaling role for extracellular adenosine triphosphates and diphosphates in Arabidopsis. Plant Cell 16(10):2652-64, 2004. e-Pub 2004. PMID: 15367717.
- Steinebrunner I, Jeter CR, Song C, Roux SJ. Molecular and biochemical Comparison of two different apyrases from Arabidopsis thaliana. Plant Physiology and Biochemistry 38:913-922, 2000. e-Pub 2000.
Invited Articles
- Gong S, Li Q, Jeter CR, Fan Q, Tang DG, Liu B. Regulation of NANOG in cancer cells. Mol Carcinog 54(9):679-87, 2015. e-Pub 2015. PMID: 26013997.
- Jeter CR, Yang T, Wang J, Chao HP, Tang DG. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells 33(8):2381-90, 2015. e-Pub 2015. PMID: 25821200.
- Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter CR. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46(1):1-14, 2007. e-Pub 2007. PMID: 16921491.
Manuals, Teaching Aids, Other Teaching Publications
- . Zeiss Lightsheet 7, 2023.
- . OMX Structured Illumination Microscopy (SIM), 2023.
- . FRET/FRAP, 2019.
- . Vibratome Sectioning Protocol, 2018.
- . Leica TCS SP8 Multiphoton Microscope Standard Operating Procedure, 2018.
- . LSM880 Unmixing Spectral Crosstalk Standard Operating Procedure, 2017.
- . Laser Microirradiation Standard Operating Procedure, 2017.
- . LSM880 AiryScan Super-resolution Imaging Standard Operating Procedure, 2017.
- . Immunofluorescence Staining Protocol, 2017.
- . Zeiss LSM880 Confocal Standard Operating Procedure, 2016.
Other Articles
- Mise, K, Long, J, Galvan, D, Ye, Z, Fan, G, Sharma, R, Serysheva, I, Moore, T, Jeter, CR, Anna Zal, M, Araki, M, Wada, J, Schumacker, PT, Chang, B, Danesh, FR Correction to. Nature communications 15(1), 2024. PMID: 38589378.
- Basu S, Dong Y, Kumar R, Jeter CR, Tang DG Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Semin Cancer Biol S1044-579X(21):90-103, 2022. PMID: 33979674.
Book Chapters
- Jeter, CR. Investigating the Role of the Embryonic Stem Cell Self-Renewal Gene NANOG in Neoplastic Processes. In: Stem Cells and Cancer Stem Cells. Springer, 2013.
- Jeter, CR, Tang, DG. Prostate Tissue Stem Cells and Prostate Cancer Progression. In: Encyclopedia of Molecular Cell Biology and Molecular Medicine. Wiley-VCH, 2012.
- Jeter CR, Tang DG. Prostate cancer stem cells. In: Cancer Stem Cells. Cambridge University Press, 2009.
- Roux S, Song C, Jeter CR. Regulation of plant growth and development by extracellular nucleotides. In: Communication in Plants. Springer, 221-234, 2006.
Selected Presentations & Talks
Local Presentations
- 2025. Hosted: TauSTED Xtend Gentle super-resolution microscopy. Invited. Hosted: TauSTED Xtend Gentle super-resolution microscopy. Houston, Texas, US.
- 2025. Hosted: Breaking through resolution barriers;Introducing the ONI Nanoimager super-resolution microscope. Invited. Hosted: Breaking through resolution barriers;Introducing the ONI Nanoimager super-resolution microscope. Houston, Texas, US.
- 2024. Hosted: Cell DIVE Multiplexed Imaging with Aivia AI-driven image analysis software. Invited. Hosted: Cell DIVE Multiplexed Imaging with Aivia AI-driven image analysis software. Houston, Texas, US.
- 2024. Hosted: Automated High Content Imaging and Analysis with ImageXpress Confocal HTai. Invited. Hosted: Automated High Content Imaging and Analysis with ImageXpress Confocal HTai. Houston, Texas, US.
- 2024. Flourescence Microscopy Services at MDACC South Campus. Invited. University of Texas MDA Cancer Center Townhall. Houston, Texas, US.
- 2024. Hosted: IMARIS Workshop 3D/4D Visualization & Analysis. Invited. Hosted: IMARIS Workshop 3D/4D Visualization & Analysis. Houston, Texas, US.
- 2023. Hosted: Super-Resolution Microscopy Demo and Workshop for the Nikon AX R NSPARC with iLas Ring TIRF and SMLM. Conference. Hosted: Super-Resolution Microscopy Demo and Workshop for the Nikon AX R NSPARC with iLas Ring TIRF and SMLM. Houston, TX, US.
- 2023. Hosted: Andor DragonFly Spinning Disk Confocal Seminar and Demo. Conference. Hosted: Andor DragonFly Spinning Disk Confocal Seminar and Demo. Houston, TX, US.
- 2023. Hosted: Introducing Nikon AX/AX R with NSPARC. Invited. Hosted: Introducing Nikon AX/AX R with NSPARC. Houston, Texas, US.
- 2023. Hosted: Zeiss Lightsheet Seminar and Demo/Workshop. Conference. Hosted: Zeiss Lightsheet Seminar and Demo/Workshop. Houston, TX, US.
- 2023. Hosted: ZEISS Lattice Lightsheet 7 Discovering the subcellular dynamics of life with ZEISS Lattice Lightsheet 7. Invited. Hosted: ZEISS Lattice Lightsheet 7 Discovering the subcellular dynamics of life with ZEISS Lattice Lightsheet 7. Houston, Texas, US.
- 2023. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Conference. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Houston, TX, US.
- 2023. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Conference. Hosted: Zeiss. Gaussian Lightsheet (LS7) Microscopy Seminar/Workshop and Open House. Houston, TX, US.
- 2023. The Advanced Microscopy Core and EMC Cell Imaging: High Resolution Optical Microscopy. Conference. The Advanced Microscopy Core and EMC Cell Imaging: High Resolution Optical Microscopy. Houston, TX, US.
Regional Presentations
- 2023. Work-in-Progress. Conference. Work-in-Progress, US.
- 2021. Work-in-Progress. Conference. Work-in-Progress, US.
- 2019. Work-in-Progress. Conference. Work-in-Progress, US.
- 2018. Work-in-Progress. Conference. Work-in-Progress, US.
- 2017. Work-in-Progress. Conference. Work-in-Progress, US.
- 2016. Epigenetics. Conference. Epigenetics, US.
- 2016. Work-in-Progress. Conference. Work-in-Progress, US.
- 2015. Work-in-Progress. Conference. Work-in-Progress, US.
- 2013. Molecular Oncogenesis. Conference. Molecular Oncogenesis, US.
- 2012. Genetics. Conference. Genetics, US.
National Presentations
- 2020. Tissue preparation and immunofluorescence staining for multispectral volumetric multiphoton and confocal microscopy. Conference. Tissue preparation and immunofluorescence staining for multispectral volumetric multiphoton and confocal microscopy. Palm Springs, CA, US.
- 2014. NANOG regulation of prostate tumorigenesis. Conference. NANOG regulation of prostate tumorigenesis. Keystone, CO, US.
- 2012. Molecular oncogenesis of NANOG in castration-resistant prostate cancer. Conference. Molecular oncogenesis of NANOG in castration-resistant prostate cancer, US.
- 2009. A novel strategy to isolate live label-retaining cells from prostate tumors. Conference. Research Scholar's Program, US.
- 2008. Essential role of the self-renewal gene Nanog in regulating tumor development. Conference. Essential role of the self-renewal gene Nanog in regulating tumor development, US.
International Presentations
- 2025. Advanced Microscopy Core Facility - UT MD Anderson Cancer Center. Poster. Texas Society of Microscopy Annual Meeting. Houston, US.
- 2023. High Throughput Mutant Library Screening via Confocal Microscopy Spatial Analysis. Conference. High Throughput Mutant Library Screening via Confocal Microscopy Spatial Analysis. Porto, PT.
- 2023. Usp22 loss of function leads to Purkinje cells degeneration and glial deregulation in the cerebellum of adult mice. Conference. Usp22 loss of function leads to Purkinje cells degeneration and glial deregulation in the cerebellum of adult mice. British Columbia, CA.
- 2010. Nanog: Origins and implications in cancer cells. Conference. Nanog: Origins and implications in cancer cells, US.
- 2005. Cancer stem-like cells in human cancer cell cultures and xenograft tumors: Expression and roles of 'stemness' genes. Conference. Cancer stem-like cells in human cancer cell cultures and xenograft tumors: Expression and roles of 'stemness' genes, US.
Formal Peers
- 2013. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. Invited. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer, TX, US.
- 2013. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. Invited. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. San Antonio, TX, US.
- 2012. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. Invited. Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer. College Station, TX, US.
- 2009. The Molecular Basis of the Resemblance of Cancer Cells and Stem Cells. Invited. The Molecular Basis of the Resemblance of Cancer Cells and Stem Cells. Temple, TX, US.
Grant & Contract Support
| Date: | 2025 - 2026 |
| Title: | Custom Nikon NSPARC/iLas RingTIRF/SMLM Super-resolution Microscope |
| Funding Source: | NIH |
| Role: | PI |
| ID: | S10OD038152 |
| Date: | 2024 - 2028 |
| Title: | Noncanonical roles of Bim in heat shock-induced cell death |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | R01GM155335-01 |
| Date: | 2024 - 2029 |
| Title: | Defeating Cancer with Immunomodulatory Bacterial Therapeutics |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00020827 |
| Date: | 2024 - 2029 |
| Title: | Interrogating and Targeting the Neuro-immune Axis in Recurrent GBM |
| Funding Source: | NIH/NINDS |
| Role: | Collaborator |
| ID: | R01 NS136160-01 |
| Date: | 2023 - 2028 |
| Title: | Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma |
| Funding Source: | NIH/NINDS |
| Role: | Co-I |
| ID: | R01 NS127922-01A1 |
| Date: | 2021 - 2022 |
| Title: | Illuminating pathogenesis via Elyra 7 Lattice SIM Super-resolution Microscopy |
| Funding Source: | NIH |
| Role: | PI |
| ID: | S10 OD030241 |
| Date: | 2018 - 2020 |
| Title: | Cancer stem cell-induced remodeling of the bone marrow niche |
| Funding Source: | Emerson Collective Cancer Research Fund |
| Role: | PI |
| Date: | 2018 - 2023 |
| Title: | Defining USP22 Functions During Mammalian Development |
| Funding Source: | NIH/NICHD |
| Role: | Co-I |
| ID: | R01 HD094400-05A1 |
| Date: | 2017 - 2019 |
| Title: | Cancer stem cell-induced remodeling of the bone marrow niche |
| Funding Source: | Institutional/IRG |
| Role: | PI |
| ID: | IRG |
| Date: | 2017 - 2023 |
| Title: | The University of Texas MD Anderson Cancer Center Science Park Flow Cytometry and Cell Imaging Core |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Collaborator |
| ID: | RP170628 |
| Date: | 2016 - 2018 |
| Title: | Cancer stem cell-induced remodeling of the tumor microenvironment |
| Funding Source: | Institutional/IRG |
| Role: | PI |
| ID: | IRG |
| Date: | 2012 - 2015 |
| Title: | Molecular Oncogenesis of NANOG in Castration-Resistant Prostate Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP120394 |
| Date: | 2011 - 2014 |
| Title: | Characterization of Slow-Cycling Prostate Cancer Cells as Potential Therapeutic Targets |
| Funding Source: | DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP) |
| Role: | PI |
| ID: | W81XWH-10-PCRP-IDA (PC101049) |
| Date: | 2011 - 2012 |
| Title: | A Novel Transgenic Mouse Model to Study the Impact of Environmental Xenoestrogens on Slow-Cycling Prostate Stem Cell Susceptibility to Transformation |
| Funding Source: | NIEHS/CRED |
| Role: | PI |
| ID: | CRED |
| Date: | 2007 - 2009 |
| Title: | A Novel Strategy to Isolate Live Label-Retaining Cells from Prostate Tumors |
| Funding Source: | The American Urological Association Research Foundation |
| Role: | PI |
| Title: | The BRCA1-WWOX interaction in breast cancer development and treatment resistance |
| Funding Source: | Department of Defense (DOD) |
| Role: | Co-I |
| ID: | 1252745 |
Patient Reviews
CV information above last modified April 02, 2025